Patents (1374 Stem Cell Patents)

Class: Expansion (410)

Order by:
<< | < | 7 8 9 10 11 12 13 14 15 | > | >>


Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds

Patent Number: 7,211,600

It is known that tumor stem cells share many properties with non-malignant stem cells, such as expression of CD133. The receptor for stem cell factor, c-kit, is found on numerous types of normal stem cells in addition to hematopoietic stem cells, where it was originally discovered. This current patent...

Inventors: Lipson; Ken (San Mateo, CA), McMahon; Gerald (Kenwood, CA)
Assignee: Sugen Inc. (South San Francisco, CA)
Date of First Priority Issue: Wednesday December 22nd, 1999

Nitric oxide manipulation of muscle satellite cell activation

Patent Number: 6967102

This patent sounds (from its title) like it covers use of nitric oxide for activation of muscle stem cells. Given the inventor described a role for nitric oxide in this context (Anderson JE A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells. Mol Biol Cell. 2000 May;11(5):1859-74 janders@ms.umanitoba.ca), one would anticipate the claims to...

Inventor: Anderson, Judy E. (Winnipeg, CA)
Assignee: University of Manitoba (Winnipeg, CA)
Date of First Priority Issue: Wednesday November 3rd, 1999

Isolation and expansion of human marrow stromal cells

Patent Number: 7,374,937

This patent covers methods of expanding bone marrow stromal cells by culture at low concentrations.  The stromal cells described in the patent are very similar in morphology and marker profile to mesenchymal stem cells that are already in clinical trials.

Methods disclosed by the patent include ways of inducing proliferation of isolated human bone marrow stromal cells by culturing...

Inventors: Prockop; Darwin J. (New Orleans, LA), Colter; David (Philadelphia, PA), DiGirolamo; Carla (Milford, MA)
Assignee: Philadelphia Health and Education Corporation (Philadelphia, PA)
Date of First Priority Issue: Friday October 29th, 1999

Method for culturing langerhans islets and islet autotransplantation islet regeneration

Patent Number: 6506599

This patent teaches how to expand autologous or allogeneic islet stem cells and to generate from them islets useful for the treatment of diabetes. The culture techniques disclosed involve cytokine, matrix and antibody cocktails. This invention may be useful in conjunction with the various embryonic stem cell technologies that are currently being studied.

Inventor: Yoon, Tai-Wook (Seodaemoon-Ku Seoul, KR)
Assignee: None stated
Date of First Priority Issue: Friday October 15th, 1999

Regulators of the hedgehog pathway, compositions and uses related thereto

Patent Number: 7098196

This patent is useful for parties seeking to inhibit signal transduction pathways in stem cells, pathways such as the smoothened-dependent pathway. The patent is primarily important for the treatment of cancer, where one tries to inhibit stem cells that give rise to other tumor cells, although numerous uses in regenerative medicine are also possible. The patent has 5 independent claims, all...

Inventors: Beachy, Philip A. (Ruxton, MD); Chen, James K. (Baltimore, MD); Taipale, Anssi J. (Baltimore, MD)
Assignee: Johns Hopkins University School of Medicine (Baltimore, MD)
Date of First Priority Issue: Wednesday October 13th, 1999

Mediators of hedgehog signaling pathways, compositions and uses related thereto

Patent Number: 6545005

This patent provides compositions of matter that target signalling through the hedgehog pathway. This is important for inhibition of cancer cells since in many cases they have constitutive activation of the hedgehog pathway.

Inventors: Baxter, Anthony David (Abingdon, GB); Boyd, Edward Andrew (Didcot, GB); Guicherit, Oivin M. (Belmont, MA); Price, Stephen (Aylesbury, GB); Rubin, Lee D. (Wellesley, MA)
Assignee: Curtis, Inc. (Cambridge, MA)
Date of First Priority Issue: Thursday September 16th, 1999

Brain cell or nerve cell-protecting agents comprising medicinal ginseng

Patent Number: 7,235,267

Numerous people believe that natural remedies are not patentable. This is not correct. In this specific patent, the use of ginsenoside Rb1 for acceleration of post CNS-infarct healing is covered. While numerous ginseng components have been known to have neuroprotective activities, this patent overcomes obviousness challenges by claiming only specific chemical...

Inventors: Sakanaka; Masahiro (Ehime, JP), Maeda; Nobuji (Ehime, JP), Tanaka; Junya (Ehime, JP), Nakata; Kimihiko (Ehime, JP)
Assignee: Japan Science and Technology Corporation (Saitama, JP)
Date of First Priority Issue: Monday August 30th, 1999

TGF-.alpha. polypeptides, functional fragments and methods of use therefor

Patent Number: 6677307

This patent discloses compositions of transforming growth factor alpha peptides and pharmaceutical preparations thereof. The patent is useful for expanding certain stem cells that respond to this cytokine. One potential use is for treatment of mucositis.

Inventors: Twardzik, Daniel R. (Bainbridge Island, WA); Pernet, Andre (Lake Forest, IL); Felker, Thomas S. (Vashon, WA); Paskell, Stefan (Bainbridge Island, WA); Reno, John M. (Brier, WA)
Assignee: Kaleidos Pharma, Inc. (Seattle, WA)
Date of First Priority Issue: Thursday August 19th, 1999

Nicotine receptor agonists in stem cell and progenitor cell recruitment

Patent Number: 6720340

This patent teaches that nicotine may be used for mobilization of stem cells. It covers endothelial precursor cells as well.

Inventors: Cooke, John (Palo Alto, CA); Johnson, Frances Lauri (Portola Valley, CA); Pathak, Anjali (Campbell, CA); Jang, James (San Bruno, CA); Tsao, Phillip (San Jose, CA); Heeschen, Christopher (Menlo Park, CA)
Assignee: The Board of Trustees of the Leland Stanford, Jr. Unversity (Palo Alto, CA)
Date of First Priority Issue: Wednesday July 28th, 1999

Fibroblast growth factor and nucleic acids encoding same

Patent Number: 7056885

The invention covers a novel type of fibroblast growth factor called FGF-CX, which is useful for differentiation and expansion of various stem cells. The patent has 2 independent claims: 1 for the composition of matter itself, and the second for the composition of matter together with a pharmaceutically applicable carrier.

Inventors: Jeffers, Michael (Branford, CT); Shimkets, Richard A. (West Haven, CT); Prayaga, Sudhirdas K. (East Haven, CT); Boldog, Ferenc L. (North Haven, CT); Yang, Meijia (East Lyme, CT); Burgess, Catherine (Wethersfield, CT); Fernandes, Elma (Branford, CT); Herrm
Assignee: CuraGen Corporation (Branford, CT)
Date of First Priority Issue: Tuesday July 27th, 1999

Order by:
<< | < | 7 8 9 10 11 12 13 14 15 | > | >>




Home | News | Patents | Products | Journal | Jobs | Search | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2009 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.03